- Home
- PMN vs KALA Comparison
PMN vs KALA Comparison
Compare PMN & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- KALA
- Stock Information
- Founded
- PMN 2004
- KALA 2009
- Country
- PMN Canada
- KALA United States
- Employees
- PMN N/A
- KALA N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- KALA Health Care
- Exchange
- PMN Nasdaq
- KALA Nasdaq
- Market Cap
- PMN 23.5M
- KALA 26.2M
- IPO Year
- PMN N/A
- KALA 2017
- Fundamental
- Price
- PMN $0.42
- KALA $0.80
- Analyst Decision
- PMN Strong Buy
- KALA Buy
- Analyst Count
- PMN 3
- KALA 3
- Target Price
- PMN $4.33
- KALA $31.50
- AVG Volume (30 Days)
- PMN 819.9K
- KALA 875.4K
- Earning Date
- PMN 11-13-2025
- KALA 11-07-2025
- Dividend Yield
- PMN N/A
- KALA N/A
- EPS Growth
- PMN N/A
- KALA N/A
- EPS
- PMN N/A
- KALA N/A
- Revenue
- PMN N/A
- KALA N/A
- Revenue This Year
- PMN N/A
- KALA N/A
- Revenue Next Year
- PMN N/A
- KALA N/A
- P/E Ratio
- PMN N/A
- KALA N/A
- Revenue Growth
- PMN N/A
- KALA N/A
- 52 Week Low
- PMN $0.38
- KALA $0.77
- 52 Week High
- PMN $1.59
- KALA $20.60
- Technical
- Relative Strength Index (RSI)
- PMN 41.57
- KALA 26.34
- Support Level
- PMN $0.41
- KALA $0.77
- Resistance Level
- PMN $0.48
- KALA $0.83
- Average True Range (ATR)
- PMN 0.04
- KALA 0.10
- MACD
- PMN -0.00
- KALA 0.35
- Stochastic Oscillator
- PMN 5.00
- KALA 3.31
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.